Treatment of mycobacterial infections in HIV-negative immunocompromised patients.
Rifabutin is a useful drug in the treatment of patients with rifampicin-resistant mycobacteriosis or with rifampicin intolerance. Rifabutin is the preferable drug in patients infected with mycobacteria who concomitantly receive immunosuppressive drugs, because interactions with these are less prominent than with rifampicin.
Heurlin
N
N
Department of Respiratory and Allergic Diseases, Huddinge University Hospital, Sweden.
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D018023:HIV Seronegativity; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D009164:Mycobacterium Infections / Q000188:drug therapy* / Q000276:immunology; D017828:Rifabutin / Q000627:therapeutic use*
D000904:Antibiotics, Antitubercular; D017828:Rifabutin